The patient has malignant hyperthermia, an adverse event associated with some anesthesia drugs (ie succinylcholine). The DOC for treating malignant hyperthermia is Dantrolene, which antagonizes the ryanodine receptor and results in decreased intracellular calcium.
to snoo-finity ... and beyond!
submitted by cbrodo(14), 2019-07-11T01:17:24Z
The patient has malignant hyperthermia, an adverse event associated with some anesthesia drugs (ie succinylcholine). The DOC for treating malignant hyperthermia is Dantrolene, which antagonizes the ryanodine receptor and results in decreased intracellular calcium.